[1]
SARKAR, P. et al. 2022. BIPHASIC DISSOLUTION MODEL: NOVEL STRATEGY FOR DEVELOPING DISCRIMINATORY IN VIVO PREDICTIVE DISSOLUTION MODEL FOR BCS CLASS II DRUGS. International Journal of Pharmacy and Pharmaceutical Sciences. 14, 4 (Apr. 2022), 20–27. DOI:https://doi.org/10.22159/ijpps.2022v14i4.44042.